company background image
6550 logo

Polaris Group TWSE:6550 Stock Report

Last Price

NT$44.85

Market Cap

NT$33.5b

7D

0%

1Y

-37.0%

Updated

30 Jan, 2025

Data

Company Financials

6550 Stock Overview

Offers biotechnology, drug testing, and contract development and manufacturing services. More details

6550 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Polaris Group Competitors

Price History & Performance

Summary of share price highs, lows and changes for Polaris Group
Historical stock prices
Current Share PriceNT$44.85
52 Week HighNT$78.00
52 Week LowNT$43.00
Beta0.62
1 Month Change-1.75%
3 Month Change-11.89%
1 Year Change-37.01%
3 Year Change-36.11%
5 Year Change175.32%
Change since IPO-59.35%

Recent News & Updates

Does Polaris Group (TWSE:6550) Have A Healthy Balance Sheet?

Jan 13
Does Polaris Group (TWSE:6550) Have A Healthy Balance Sheet?

Recent updates

Does Polaris Group (TWSE:6550) Have A Healthy Balance Sheet?

Jan 13
Does Polaris Group (TWSE:6550) Have A Healthy Balance Sheet?

Shareholder Returns

6550TW BiotechsTW Market
7D0%0%0%
1Y-37.0%14.7%28.6%

Return vs Industry: 6550 underperformed the TW Biotechs industry which returned 14.7% over the past year.

Return vs Market: 6550 underperformed the TW Market which returned 28.6% over the past year.

Price Volatility

Is 6550's price volatile compared to industry and market?
6550 volatility
6550 Average Weekly Movement5.5%
Biotechs Industry Average Movement4.9%
Market Average Movement4.4%
10% most volatile stocks in TW Market7.8%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 6550 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 6550's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1988n/aSteve Hsuwww.polaris-group.com

Polaris Group, together with its subsidiaries, offers biotechnology, drug testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It develops ADI-PEG 20 for the treatment of various cancer indications.

Polaris Group Fundamentals Summary

How do Polaris Group's earnings and revenue compare to its market cap?
6550 fundamental statistics
Market capNT$33.47b
Earnings (TTM)-NT$2.25b
Revenue (TTM)NT$75.65m

442.4x

P/S Ratio

-14.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6550 income statement (TTM)
RevenueNT$75.65m
Cost of RevenueNT$122.18m
Gross Profit-NT$46.53m
Other ExpensesNT$2.20b
Earnings-NT$2.25b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-3.01
Gross Margin-61.50%
Net Profit Margin-2,972.75%
Debt/Equity Ratio24.2%

How did 6550 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 23:00
End of Day Share Price 2025/01/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Polaris Group is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yenya KuoCapital Securities Corporation